NCT04997785

Brief Summary

The study is a multicenter single-blinded randomized comparative trial. Adult patients older than 20 years of age presenting with acute hip fracture in emergency department between January 1st, 2021 and December 31st, 2021 will be enrolled. (NOTE: The study was paused temporarily due to local SARS-2 COVID-19 virus pandemic restrictions. Finally, we conducted the study from August 30th, 2021 to May 08th, 2022.) Included patients will receive analgesia with either pericapsular nerve group (PENG) block or intravenous morphine. The primary outcome measure was pain scores (Numeric Rating Scale (NRS) 0 to 10) at rest and with movement. Secondary outcomes were rescue opioids use, complications, length of hospital stay, and patient-reported outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 10, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

August 30, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2022

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

8 months

First QC Date

July 22, 2021

Last Update Submit

January 15, 2023

Conditions

Keywords

Pericapsular Nerve Group Block (PENG Block)

Outcome Measures

Primary Outcomes (1)

  • Pain intensity difference (PID)

    Pain intensity was investigated at rest and with movement using the 11-point numeric rating-scale (NRS) from 0 (no pain) to 10 (worst pain), and pain-intensity difference(PID) represents the difference in NRS scores between any observation time and the baseline.

    24 hours

Secondary Outcomes (5)

  • postdose quadriceps strength

    24 hours

  • Rescue opioid consumption

    24 hours

  • Incidence of nerve block complications

    24 hours

  • Incidence of opioid side effects

    24 hours

  • Patient-reported outcome

    24 hours

Study Arms (2)

Ultrasound-guided Pericapsular Nerve Group (PENG) Block

EXPERIMENTAL

PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.

Procedure: Ultrasound-guided Pericapsular Nerve Group (PENG) Block

Intravenous Morphine

ACTIVE COMPARATOR

Dosage of intravenous morphine was determined according to 0.1 mg per kg; EPs were instructed to aim to reduce the pain by 50% or per patient request.

Procedure: Ultrasound-guided Pericapsular Nerve Group (PENG) Block

Interventions

PENG blocks is performed by Emergency Medicine board-certified emergency physicians (EPs) with standard training program. PENG block is performed using a spinal needle (NIPRO® 21G × 70 mm) at the level of of anterior superior iliac spine, parallel to the inguinal crease, with real-time ultrasound guidance, according to the steps published by Girón-Arango et al in 2018. The investigators use 20 ml of 1% lidocaine for nerve block because this drug has a short onset time, which is adequate to relieve pain before surgical intervention.

Intravenous MorphineUltrasound-guided Pericapsular Nerve Group (PENG) Block

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged \>20 years presenting to the ED with a diagnosis of traumatic hip fracture during the study timeframe.

You may not qualify if:

  • are aged \<20 years
  • coagulopathy
  • injection site infection
  • allergy to opioids or local anesthetics
  • initial pulse oximetry measures of oxygen saturation \<92%
  • initial systolic blood pressure \< 90 mmHg
  • chronic opioid use
  • non-communicative
  • major trauma
  • fractures happened \> 24 hours
  • request conservative(non-operative) treatments.
  • The investigators also exclude patients if the NB providers are unavailable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Chiayi City, 622, Taiwan

Location

MeSH Terms

Conditions

Hip FracturesAcute PainEmergencies

Interventions

Dental Occlusion

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Emergency department physician, Principal Investigator

Study Record Dates

First Submitted

July 22, 2021

First Posted

August 10, 2021

Study Start

August 30, 2021

Primary Completion

May 8, 2022

Study Completion

May 8, 2022

Last Updated

January 18, 2023

Record last verified: 2023-01

Locations